Amgen partners with the NHS and other organisations for the benefit of patients and in a way that is true to the Industry Codes of Practice and Amgen’s policy. Amgen is committed to making public the scope of its partnerships in the UK and Ireland in order to increase transparency. This includes stating the transfers of value associated with all collaborative working projects each year.
| Academic Health Science Network for the North East and North Cumbria (AHSN-NENC) | £ 11,509 |
| Barts Health NHS Trust on behalf of North Thames Genomics Laboratory Hub | £ 10,897 |
| Buckinghamshire Clinical Commissioning Group | £ 35 |
| Cardiff & Vale University Health Board | £70,000 |
| Hywel Dda University Health Board | £114,600 |
| Innovation Agency, Academic Health Science Network for the North West Coast | £11,509 |
| Manchester University NHS Foundation Trust on behalf of North West Genomics Laboratory Hub | £67,093 |
| NHS South East London Integrated Care Board | £80,000 |
| Nottingham University Hospitals NHS Trust | £140 |
| Royal Devon & Exeter NHS Foundation Trust on behalf of NHS South West Genomic Medicine Service Alliance | £64,261 |
| University Hospitals of Leicester NHS Trust | £70 |